UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis

The American journal of gastroenterology, 2019-07, Vol.114 (7), p.1043-1050

2019

Volltextzugriff (PDF)

Morning light treatment for inflammatory bowel disease: a clinical trial

BMC gastroenterology, 2024-05, Vol.24 (1), p.179-179, Article 179

2024

Volltextzugriff (PDF)

The Microbiome in Quiescent Crohn’s Disease With Persistent Symptoms Show Disruptions in Microbial Sulfur and Tryptophan Pathways

Gastro hep advances, 2024, Vol.3 (2), p.167-177

2024

Volltextzugriff (PDF)

A Patient Perspective on Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn’s Disease

Clinical gastroenterology and hepatology, 2022-02, Vol.20 (2), p.469-470

2022

Volltextzugriff (PDF)

Timing Is Everything: The Lifesaving Potential of Early Medical Therapy in Acute Severe Ulcerative Colitis

The American journal of gastroenterology, 2024-06

2024

Volltextzugriff (PDF)

Sphingosine 1-Phosphate Receptor Modulators are Effective in Patients With Moderately to Severely Active Ulcerative Colitis and a Prior Biologic Exposure: A Meta-Analysis of Randomized Controlled Trials

Clinical gastroenterology and hepatology, 2024-05, Vol.22 (5), p.1139-1141.e3

2024

Volltextzugriff (PDF)

Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study

Clinical gastroenterology and hepatology, 2021-10, Vol.19 (10), p.2112-2120.e1

2021

Volltextzugriff (PDF)

Editorial: estimating the costs of care in irritable bowel syndrome—a necessary step to enhance value‐based care for a high‐prevalence, low‐cost condition

Alimentary pharmacology & therapeutics, 2022-06, Vol.55 (12), p.1588-1589

2022

Volltextzugriff (PDF)

Improving Detection Rates of Giardia Using Duodenal Biopsy PCR: Is the Juice Worth the Squeeze?

Digestive diseases and sciences, 2020-08, Vol.65 (8), p.2156-2157

2020

Volltextzugriff (PDF)

Life-Threatening Gastrointestinal Bleeding in an Immunocompromised Patient

Gastroenterology (New York, N.Y. 1943), 2021-09, Vol.161 (3), p.e6-e7

2021

Volltextzugriff (PDF)

In-hospital management of inflammatory bowel disease

Current opinion in gastroenterology, 2023-07, Vol.39 (4), p.274-286

2023

Volltextzugriff (PDF)

Efficacy and Safety of Sphingosine 1-Phosphate Receptor Modulators for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Journal of clinical gastroenterology, 2024-09, Vol.58 (8), p.753

2024

Volltextzugriff (PDF)

Use of Upadacitinib in 16 Tofacitinib-refractory Ulcerative Colitis Patients: A Single-center Case 2Series

Inflammatory bowel diseases, 2023-12

2023

Volltextzugriff (PDF)

Racial Disparity in Esophageal Squamous Cell Carcinoma Treatment and Survival in the United States

The American journal of gastroenterology, 2024-05, Vol.119 (5), p.830-836

2024

Volltextzugriff (PDF)

Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis

Clinical gastroenterology and hepatology, 2019-04, Vol.17 (5), p.988-990.e1

2019

Volltextzugriff (PDF)

Legalization of Cannabis Does Not Reduce Opioid Prescribing in Patients With Inflammatory Bowel Disease: A Difference-in-Difference Analysis

The American journal of gastroenterology, 2024-05

2024

Volltextzugriff (PDF)

Efficacy and Safety of Dual Targeted Therapy for Partially or Non-responsive Inflammatory Bowel Disease: A Systematic Review of the Literature

Digestive diseases and sciences, 2023-06, Vol.68 (6), p.2604-2623

2023

Volltextzugriff (PDF)

The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Inflammatory bowel diseases, 2022-12, Vol.28 (12), p.1904-1914

2022

Volltextzugriff (PDF)

Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn’s Disease: A Systematic Review

Clinical gastroenterology and hepatology, 2022-04, Vol.20 (4), p.817-846.e10

2022

Volltextzugriff (PDF)

Understanding the Perspectives and Experiences of Patients with Acute Severe Ulcerative Colitis in the Hospital: A Qualitative Analysis

Digestive diseases and sciences, 2024-09

2024

Volltextzugriff (PDF)

Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience

The American journal of gastroenterology, 2024-07, Vol.119 (7), p.1421-1425

2024

Volltextzugriff (PDF)

Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19

Digestive diseases and sciences, 2021-09, Vol.66 (9), p.3192-3198

2021

Volltextzugriff (PDF)

Correction to: Efficacy and Safety of Dual Targeted Therapy for Partially or Non‑responsive Inflammatory Bowel Disease: A Systematic Review of the Literature

Digestive diseases and sciences, 2023-12, Vol.68 (12), p.4540-4540

2023

Volltextzugriff (PDF)

Characteristics of Facilities With Early and Rapid Ustekinumab Adoption for Patients With Inflammatory Bowel Disease

The American journal of gastroenterology, 2023-09, Vol.118 (9), p.1688-1692

2023

Volltextzugriff (PDF)

AXL Is a Potential Target for the Treatment of Intestinal Fibrosis

Inflammatory bowel diseases, 2021-03, Vol.27 (3), p.303-316

2021

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(108)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(46)
Science & Technology
(46)
Gastroenterology & Hepatology
(34)
Humans
(34)
Inflammatory Bowel Disease
(15)
Male
(13)
Female
(12)
Ulcerative Colitis
(9)
Adult
(8)
Gastroenterology
(8)
Middle Aged
(8)
Oncology
(8)
Patients
(8)
Health Aspects
(7)
Medicine
(7)
Medicine & Public Health
(7)
Biochemistry
(6)
Crohn's Disease
(6)
Hepatology
(6)
Inflammatory Bowel Diseases - Therapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis

Morning light treatment for inflammatory bowel disease: a clinical trial

The Microbiome in Quiescent Crohn’s Disease With Persistent Symptoms Show Disruptions in Microbial Sulfur and Tryptophan Pathways

A Patient Perspective on Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn’s Disease

Timing Is Everything: The Lifesaving Potential of Early Medical Therapy in Acute Severe Ulcerative Colitis

Sphingosine 1-Phosphate Receptor Modulators are Effective in Patients With Moderately to Severely Active Ulcerative Colitis and a Prior Biologic Exposure: A Meta-Analysis of Randomized Controlled Trials

Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study

Editorial: estimating the costs of care in irritable bowel syndrome—a necessary step to enhance value‐based care for a high‐prevalence, low‐cost condition

Improving Detection Rates of Giardia Using Duodenal Biopsy PCR: Is the Juice Worth the Squeeze?

Life-Threatening Gastrointestinal Bleeding in an Immunocompromised Patient

In-hospital management of inflammatory bowel disease

Efficacy and Safety of Sphingosine 1-Phosphate Receptor Modulators for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Use of Upadacitinib in 16 Tofacitinib-refractory Ulcerative Colitis Patients: A Single-center Case 2Series

Racial Disparity in Esophageal Squamous Cell Carcinoma Treatment and Survival in the United States

Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis

Legalization of Cannabis Does Not Reduce Opioid Prescribing in Patients With Inflammatory Bowel Disease: A Difference-in-Difference Analysis

Efficacy and Safety of Dual Targeted Therapy for Partially or Non-responsive Inflammatory Bowel Disease: A Systematic Review of the Literature

The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn’s Disease: A Systematic Review

Understanding the Perspectives and Experiences of Patients with Acute Severe Ulcerative Colitis in the Hospital: A Qualitative Analysis

Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience

Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19

Correction to: Efficacy and Safety of Dual Targeted Therapy for Partially or Non‑responsive Inflammatory Bowel Disease: A Systematic Review of the Literature

Characteristics of Facilities With Early and Rapid Ustekinumab Adoption for Patients With Inflammatory Bowel Disease

AXL Is a Potential Target for the Treatment of Intestinal Fibrosis

Suchergebnisse filtern